Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Ling Chang

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Emerging Infectious Diseases|April 19, 2017
Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012Chau-Ting Yeh, Kung-Hao Liang, Ming-Ling Chang, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Clinical Validation of a Deep Learning-Based 2D Ultrasound Steatosis Algorithm: Cutoff Transferability, Scanner Generalizability, and Comparison with FibroScanJennifer Tai, Tse-Hwa Hsu, Cheng-Jen Chen, et al.
BMC Gastroenterology|February 14, 2023
Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-upCheng-Jen Chen, Yung-Hsin Huang, Chao-Wei Hsu, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional AnalysisPo-Chang Wang, Yi-Fang Wu, Ming-Shyan Lin, et al.
Journal of Clinical Lipidology|March 26, 2018
Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidationSu-Wei Chang, Mei-Ling Cheng, Ming-Shi Shiao, et al.
Journal of Gastroenterology and Hepatology|August 6, 2014
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between gendersMing-Ling Chang, Chen-Ming Hsu, Jeng-Hwei Tseng, et al.
Journal of Medical Virology|June 9, 2016
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapyJi-Wei Lin, Ming-Ling Chang, Chao-Wei Hsu, et al.
Scientific Reports|August 2, 2016
Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphismsMing-Ling Chang, Kung-Hao Liang, Cheng-Lung Ku, et al.
Cell Transplantation|August 22, 2008
Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and toleranceJeng-Chang Chen, Ming-Ling Chang, Shiu-Feng Huang, et al.
Journal of Medical Virology|November 30, 2006
Identification of NV-F virus DNA in hepatocellular carcinomaChau-Ting Yeh, Tse-Ching Chen, Ming-Ling Chang, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Emerging Infectious Diseases|April 19, 2017
Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012Chau-Ting Yeh, Kung-Hao Liang, Ming-Ling Chang, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Clinical Validation of a Deep Learning-Based 2D Ultrasound Steatosis Algorithm: Cutoff Transferability, Scanner Generalizability, and Comparison with FibroScanJennifer Tai, Tse-Hwa Hsu, Cheng-Jen Chen, et al.
BMC Gastroenterology|February 14, 2023
Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-upCheng-Jen Chen, Yung-Hsin Huang, Chao-Wei Hsu, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional AnalysisPo-Chang Wang, Yi-Fang Wu, Ming-Shyan Lin, et al.
Journal of Clinical Lipidology|March 26, 2018
Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidationSu-Wei Chang, Mei-Ling Cheng, Ming-Shi Shiao, et al.
Journal of Gastroenterology and Hepatology|August 6, 2014
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between gendersMing-Ling Chang, Chen-Ming Hsu, Jeng-Hwei Tseng, et al.
Journal of Medical Virology|June 9, 2016
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapyJi-Wei Lin, Ming-Ling Chang, Chao-Wei Hsu, et al.
Scientific Reports|August 2, 2016
Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphismsMing-Ling Chang, Kung-Hao Liang, Cheng-Lung Ku, et al.
Cell Transplantation|August 22, 2008
Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and toleranceJeng-Chang Chen, Ming-Ling Chang, Shiu-Feng Huang, et al.
Journal of Medical Virology|November 30, 2006
Identification of NV-F virus DNA in hepatocellular carcinomaChau-Ting Yeh, Tse-Ching Chen, Ming-Ling Chang, et al.
Pageof 16